LCD L40046: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) — Palmetto GBA
Policy LCD-L40046 · Allergy/Immunology
Prepare for new billing guidelines for Allergy Immunotherapy.
Code intelligence
T78.40XA reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code T78.40XA.
Elevated code riskView ICD-10 detail
Signal breakdown
6 shown · 6 total in platform
Risk: Elevated
0
Critical
0%
5
High
83%
1
Routine
17%
0
Low
0%
New this month
+1
alerts added in last 30 days
Effective soon
1
policies effective within 30 days
High
Proposed LCD DL36408: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) — WPS
Policy LCD-DL36408 · Allergy/Immunology
Impact on allergen immunotherapy billing expected.
Proposed LCD DL40324: Allergy Diagnostic Testing — Noridian
Policy LCD-DL40324 · Allergy/Immunology
New LCD for Allergy Testing requires billing team review.
Proposed LCD DL40326: Allergy Diagnostic Testing — CGS
Policy LCD-DL40326 · Allergy/Immunology
New LCD may change allergy testing billing practices.
LCD L40341: Allergy Diagnostic Testing — WPS
Policy LCD-L40341 · Multi-specialty
WPS final LCD for allergy testing takes effect Sept 27, 2026.
LCD L33591: RAST Type Tests — Wellpoint Federal
Policy LCD-L33591 · Clinical Laboratory
RAST allergy test coverage rules active Apr 2026 under Wellpoint Federal.
Audit documentation
Building an audit file that includes T78.40XA?
The Tripwire Audit Pack exports 12 months of Allergy/Immunology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Allergy/Immunology audit pack — $349One-time purchase · not a subscription